3-Ketodigoxigenin

CAS : 4442-17-5

Ref. 3D-EAA44217

Informations sur le produit

• Nom: 3-Ketodigoxigenin
• Synonymes: (5Beta,8Xi,9Xi,12Beta)-12,14-Dihydroxy-3-Oxocard-20(22)-Enolide, (5beta)-12,beta,14-Dihydroxy-3-oxocard-20(22)-enolide, (5β,12β)-12,14-Dihydroxy-3-oxocard-20(22)-enolide, 12-beta,14-Dihydroxy-3-oxo-5-beta-card-20(22)-enolide, 12β,14β-Dihydroxy-3-oxo-5β,14β-card-20(22)-enolide, 3-Dehydrodigoxigenin, 3-Digoxigenone, 3-Oxodigoxigenin, 5-beta-Card-20(22)-enolide, 12-beta,14-dihydroxy-3-oxo-, 5β-Card-20(22)-enolide, 12β,14-dihydroxy-3-oxo-, Card-20(22)-enolide, 12,14-dihydroxy-3-oxo-, (5-beta,12-beta)-, Card-20(22)-enolide, 12,14-dihydroxy-3-oxo-, (5β,12β)-, Digoxigenin, 3-dehydro-

Description

3-Ketodigoxigenin is an analog of the cardiac glycoside digoxin that has been found in human urine. It has been shown to inhibit the growth of cancer cells by acting as a protein kinase inhibitor, leading to apoptosis or programmed cell death. This compound has been extensively studied for its anticancer potential and is being investigated as a potential medicinal agent. In Chinese medicine, 3-Ketodigoxigenin has been used to treat tumors and other cancer-related conditions. Its ability to inhibit protein kinase activity makes it a promising candidate for the development of new cancer therapeutics.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 388.5 g/mol
• Formule: C₂₃H₃₂O₅
• Degré de pureté: Min. 95%